Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.95 CHF | +0.63% | -1.60% | -6.55% |
Apr. 27 | Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022. | CI |
Apr. 26 | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
Sales 2024 * | 190M 210M | Sales 2025 * | 101M 111M | Capitalization | 2.19B 2.43B |
---|---|---|---|---|---|
Net income 2024 * | 152M 168M | Net income 2025 * | 72M 79.75M | EV / Sales 2024 * | 13.1 x |
Net Debt 2024 * | 291M 322M | Net Debt 2025 * | 324M 359M | EV / Sales 2025 * | 25 x |
P/E ratio 2024 * |
14.4
x | P/E ratio 2025 * |
13.4
x | Employees | 10 |
Yield 2024 * |
5.88% | Yield 2025 * |
6.01% | Free-Float | 97.24% |
1 day | +0.63% | ||
1 week | -1.60% | ||
1 month | -3.39% | ||
3 months | -12.77% | ||
6 months | +4.86% | ||
Current year | -6.55% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Koller
CIO | Chief Investment Officer | 54 | 03-12-31 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Meanwell
BRD | Director/Board Member | 67 | 03-12-31 |
Director/Board Member | 63 | 19-12-31 | |
Chairman | 63 | 19-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 39.95 | +0.63% | 35,810 |
24-05-30 | 39.7 | +0.13% | 62,482 |
24-05-29 | 39.65 | -1.25% | 79,034 |
24-05-28 | 40.15 | -1.11% | 44,379 |
24-05-27 | 40.6 | -.--% | 39,177 |
Delayed Quote Swiss Exchange, May 31, 2024 at 11:30 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.55% | 2.43B | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- BION Stock